Rise and shine, everyone. The middle of the week is upon us. While this may imply an extraordinarily challenging day lies ahead, we are invigorated by the presence of a bright sun overhead and a steaming cup of stimulation in hand. How else to cope? Feel free to join us, of course. Now, though, the time has come to get on with it. So here is your menu of tidbits. Hope your day is smashing and do let us know if you run across something interesting. Cheers...
Valent Pays $348M For Obagi Skin Care Company (Globe & Mail)
Biogen MS Pill Gets Eights More Years Of Patent Protection (Bloomberg News)
Savient Pharma Shares Sink On Gout Drug Sales (Associated Press)
FDA Rejects Pharmaxis Cystic Fibrosis Drug (Pharma Times)
Novo Nordisk Insulin Passes Early-Stage Study (Bloomberg News)
Roche Joins Bidding For Life Tech (Reuters)
EDITOR'S NOTE: Please check this post for additional items during the day